Jessica M Franklin1, Wesley Eddings, Sebastian Schneeweiss, Jeremy A Rassen. 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St., Suite 3030, Boston, MA, 02120, USA, JMFranklin@partners.org.
Abstract
INTRODUCTION: The Premier Perspective hospital billing database provides a promising data source for studies of inpatient medication use. However, in-hospital recording of confounders is limited, and incorporating linked healthcare claims data available for a subset of the cohort may improve confounding control. We investigated methods capable of adjusting for confounders measured in a subset, including complete case analysis, multiple imputation of missing data, and propensity score (PS) calibration. METHODS: Methods were implemented in an example study of adults in Premier undergoing percutaneous coronary intervention (PCI) in 2004-2008 and exposed to either bivalirudin or heparin. In a subset of patients enrolled in UnitedHealth for at least 90 days before hospitalization, additional confounders were assessed from healthcare claims, including comorbidities, prior medication use, and service use intensity. Diagnostics for each method were evaluated, and methods were compared with respect to the estimates and confidence intervals of treatment effects on repeat PCI, bleeding, and in-hospital death. RESULTS: Of 210,268 patients in the hospital-based cohort, 3240 (1.5 %) had linked healthcare claims. This subset was younger and healthier than the overall study population. The linked subset was too small for complete case evaluation of two of the three outcomes of interest. Multiple imputation and PS calibration did not meaningfully impact treatment effect estimates and associated confidence intervals. CONCLUSIONS: Despite more than 98 % missingness on 24 variables, PS calibration and multiple imputation incorporated confounders from healthcare claims without major increases in estimate uncertainty. Additional research is needed to determine the relative bias of these methods.
INTRODUCTION: The Premier Perspective hospital billing database provides a promising data source for studies of inpatient medication use. However, in-hospital recording of confounders is limited, and incorporating linked healthcare claims data available for a subset of the cohort may improve confounding control. We investigated methods capable of adjusting for confounders measured in a subset, including complete case analysis, multiple imputation of missing data, and propensity score (PS) calibration. METHODS: Methods were implemented in an example study of adults in Premier undergoing percutaneous coronary intervention (PCI) in 2004-2008 and exposed to either bivalirudin or heparin. In a subset of patients enrolled in UnitedHealth for at least 90 days before hospitalization, additional confounders were assessed from healthcare claims, including comorbidities, prior medication use, and service use intensity. Diagnostics for each method were evaluated, and methods were compared with respect to the estimates and confidence intervals of treatment effects on repeat PCI, bleeding, and in-hospital death. RESULTS: Of 210,268 patients in the hospital-based cohort, 3240 (1.5 %) had linked healthcare claims. This subset was younger and healthier than the overall study population. The linked subset was too small for complete case evaluation of two of the three outcomes of interest. Multiple imputation and PS calibration did not meaningfully impact treatment effect estimates and associated confidence intervals. CONCLUSIONS: Despite more than 98 % missingness on 24 variables, PS calibration and multiple imputation incorporated confounders from healthcare claims without major increases in estimate uncertainty. Additional research is needed to determine the relative bias of these methods.
Authors: Adnan Kastrati; Franz-Josef Neumann; Stefanie Schulz; Steffen Massberg; Robert A Byrne; Miroslaw Ferenc; Karl-Ludwig Laugwitz; Jürgen Pache; Ilka Ott; Jörg Hausleiter; Melchior Seyfarth; Michael Gick; David Antoniucci; Albert Schömig; Peter B Berger; Julinda Mehilli Journal: N Engl J Med Date: 2011-11-13 Impact factor: 91.245
Authors: Mirjam J Knol; Kristel J M Janssen; A Rogier T Donders; Antoine C G Egberts; E Rob Heerdink; Diederick E Grobbee; Karel G M Moons; Mirjam I Geerlings Journal: J Clin Epidemiol Date: 2010-03-25 Impact factor: 6.437
Authors: Jeremy A Rassen; Murray A Mittleman; Robert J Glynn; M Alan Brookhart; Sebastian Schneeweiss Journal: Eur Heart J Date: 2009-11-25 Impact factor: 29.983
Authors: Stefanie Schulz; Julinda Mehilli; Gjin Ndrepepa; Franz-Josef Neumann; Katrin A Birkmeier; Sebastian Kufner; Gert Richardt; Peter B Berger; Albert Schömig; Adnan Kastrati Journal: Eur Heart J Date: 2010-02-11 Impact factor: 29.983
Authors: Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran Journal: N Engl J Med Date: 2008-05-22 Impact factor: 91.245
Authors: Clémence Leyrat; Shaun R Seaman; Ian R White; Ian Douglas; Liam Smeeth; Joseph Kim; Matthieu Resche-Rigon; James R Carpenter; Elizabeth J Williamson Journal: Stat Methods Med Res Date: 2017-06-02 Impact factor: 3.021
Authors: Bernard C Silenou; Marta Avalos; Catherine Helmer; Claudine Berr; Antoine Pariente; Helene Jacqmin-Gadda Journal: PLoS One Date: 2019-01-31 Impact factor: 3.240